China

Chinese drugmakers tap GE tech, seeing biologic boom ahead
Biopharma Dive
Thu, 01/25/18 - 05:53 pm
China
biologics
GE Healthcare
Clover BioPharmaceuticals
Consortium of Chinese companies tries to acquire J&J’s LifeScan and Calibra Medical ($3-4bn)
GoinPharma
Sun, 01/21/18 - 10:43 am
China
JNJ
LifeScan
Calibra
M&A
Closing JPM18: Winners and losers, brighter days for neuroscience
Biopharma Dive
Sat, 01/13/18 - 10:58 pm
JPMHC 2018
Neurosciences
China
Sanofi
tax reform
GSK
Biogen
Celgene
channel stuffing
Indian, Chinese drugmakers eye Sanofi's European generics unit for $2B deal: report
Fierce Pharma
Thu, 01/11/18 - 11:44 pm
Sanofi
Europe
generics
China
India
Opdivo, Repatha and Lynparza likely among China’s 2018 blockbuster nods: report
Fierce Pharma
Fri, 01/5/18 - 10:28 am
China
Opdivo
Repatha
Lynparza
drug approvals
Bristol-Myers Squibb
Amgen
AstraZeneca
Eli Lilly
Gilead Sciences
Star drugs like BMS’ Opdivo, AstraZeneca’s Lynparza will get speedy OKs in China this year, new report predicts
Endpoints
Tue, 01/2/18 - 11:44 am
Bristol-Myers Squibb
AstraZeneca
Opdivo
Lynparza
China
J&J wows with a $350M cash deal to partner on CAR-T with Legend, a one-time unknown until its star turn at ASCO
Endpoints
Thu, 12/21/17 - 10:38 pm
JNJ
CAR-T
Legend Biotech
LCAR-B38M
BCMA
China
Bristol-Myers' Opdivo's Lung Cancer Study Meets Early Success
Yahoo/Zacks.com
Sun, 12/3/17 - 11:21 am
Bristol-Myers Squibb
Opdivo
clinical trials
Docetaxel
China
Bristol-Myers set to get a boost in China as Opdivo aces PhIII lung cancer study early
Endpoints
Fri, 12/1/17 - 09:32 am
Bristol-Myers Squibb
Opdivo
China
Docetaxel
lung cancer
Gilead prices hepatitis C giant Sovaldi in China at one-fifth the U.S. price: report
Fierce Pharma
Tue, 11/28/17 - 11:07 am
Gilead Sciences
hepatitis C
Sovaldi
China
drug pricing
AstraZeneca teams with China-owned fund to launch a new biopharma drug development company
Endpoints
Mon, 11/27/17 - 10:13 am
AstraZeneca
China
Dizal Pharmaceutical
Unstoppable growth of Chinese biotechs attracts over $10bn funding
GoinPharma
Mon, 11/27/17 - 09:07 am
China
biotech
Zensun
BeiGene
Chi-Med
Zai Lab
WuXi
Struggling Oncolytics Biotech signs $86.6M Asia deal with China’s Adlai Nortye
Endpoints
Fri, 11/17/17 - 10:21 am
Oncolytics
China
IV immuno-oncolytic virus
Adlai Nortye
Pfizer exits China joint venture for generic drugs
Yahoo/Reuters
Fri, 11/10/17 - 10:25 pm
Pfizer
China
generic drugs
Zhejiang Hisun Pharma
AstraZeneca executives try to shift I-O focus with China, Brilinta wins
Fierce Pharma
Fri, 11/10/17 - 09:35 am
AstraZeneca
immuno-oncology
China
Brilinta
Johnson & Johnson break ground on Chinese factory
Mass Device
Sat, 11/4/17 - 08:46 am
JNJ
Ethicon
China
device manufacturing
devices
Pharma's betting big on China, but R&D boom still to come
BioPharma Dive
Mon, 10/30/17 - 11:22 pm
China
R&D
Allergan’s intravitreal implant wins approval in China
Drug Delivery Business News
Mon, 10/30/17 - 09:54 am
Allergan
China
intravitreal implants
devices
Ozurdex
retinal vein occlusion
Big Pharma R&D is exiting China, but leaving a legacy; China’s biotech execs couldn’t be happier
Endpoints
Sat, 10/21/17 - 10:16 am
Big Pharma
China
R&D
China may relax trial requirements for new drugs, allowing foreign data
Fierce Biotech
Mon, 10/9/17 - 09:39 am
China
drug approvals
devices

Pages